Sientra Up In IPO Trading

Santa Barbara-based Sientra, a developer of aethetic medicine implants, rose in its IPO on Wednesday, trading as high as $17.90 during morning trading. The company priced last night at $15 per share, selling 5 million shares of its common stock on the NASDAQ as SIEN. The company had priced at the midpoint of its initial estimated IPO range of $14.00 to $16.00 last night. Sientra was venture backed by OrbiMed, Clarus Ventures, Abingworth MAanagement, Goldman Sachs, and TIAA-CREF, among others. Sientra makes breast and other implants.